Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8228518 | International Journal of Radiation Oncology*Biology*Physics | 2011 | 7 Pages |
Abstract
This regimen of accelerated radiotherapy with weekly cisplatin produced favorable tumor control rates and survival rates while compliance was high. However, comprehensive assessment by a multidisciplinary team of medical and paramedical specialists revealed significant long-term morbidity in the majority of the patients, with dysphagia being a major concern.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Heidi M.D., Lucas A.M. M.D., Ph.D., Geert O.R.J. M.D., Robert P. M.D., Ph.D., Simone M.A., Antoinette F. B.C., Manon B,C., Matthias A. M.D., Ph.D., Carla M.L. M.D., Ph.D., Johannes H.A.M. M.D. Ph.D.,